Synopsys, Inc. (NASDAQ:SNPS - Get Free Report) traded down 6.8% during trading on Thursday . The stock traded as low as $496.00 and last traded at $490.2930. 433,560 shares changed hands during trading, a decline of 78% from the average session volume of 1,982,338 shares. The stock had previously closed at $525.92.
Synopsys News Summary
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys delivered a beat-and-raise quarter, with adjusted EPS of $3.35 topping estimates of $3.15 and revenue rising 41.9% year over year to $2.28 billion, both above forecasts. Reuters: Synopsys raises annual forecast on demand for AI chip design software
- Positive Sentiment: The company lifted full-year guidance, signaling continued demand for its AI chip design software and stronger profitability expectations for the rest of the year. PR Newswire: Synopsys Posts Financial Results for Second Quarter Fiscal Year 2026
- Positive Sentiment: Synopsys also reached a cooperation agreement with activist investor Elliott Investment Management and added Elliott partner Jesse Cohn to its board, which could support margin improvement and shareholder-focused changes. Reuters: Synopsys reaches settlement with Elliott, says Jesse Cohn to join board
- Neutral Sentiment: Several brokerages responded positively after the report, including Bank of America raising its price target to $600 and Needham reiterating a buy rating with a $580 target, which may help support sentiment. Tickerreport: Bank of America raises price target on Synopsys
- Negative Sentiment: The stock fell anyway, likely because investors were disappointed by weakness in the chip IP business and are weighing integration risks tied to the Ansys deal and broader execution concerns. Proactive Investors: Synopsys delivers beat-and-raise, shares fall weakness in chip IP business
- Negative Sentiment: Some commentary also framed SNPS as expensive and a potential “growth trap,” suggesting valuation concerns may be limiting the stock’s reaction to the strong quarter. 247WallSt: Synopsys Is the ‘Growth Trap’ Your Advisor Won’t Warn You About
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the stock. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research report on Thursday. Citigroup upped their price target on shares of Synopsys from $580.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday, May 13th. The Goldman Sachs Group set a $600.00 price target on shares of Synopsys and gave the company a "buy" rating in a research report on Wednesday, February 25th. Rosenblatt Securities upped their price target on shares of Synopsys from $530.00 to $575.00 and gave the company a "buy" rating in a research report on Tuesday. Finally, Morgan Stanley raised their price objective on Synopsys from $480.00 to $525.00 and gave the stock an "equal weight" rating in a research note on Thursday. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $561.63.
Get Our Latest Research Report on Synopsys
Synopsys Stock Down 8.6%
The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $92.12 billion, a P/E ratio of 74.96, a P/E/G ratio of 4.38 and a beta of 1.25. The company has a 50 day simple moving average of $457.56 and a two-hundred day simple moving average of $453.69.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analysts' expectations of $2.25 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The firm's revenue for the quarter was up 41.9% compared to the same quarter last year. During the same quarter last year, the business posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities analysts predict that Synopsys, Inc. will post 10.28 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of SNPS. Sankala Group LLC bought a new position in shares of Synopsys during the 4th quarter valued at approximately $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Synopsys during the 4th quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Synopsys during the 4th quarter valued at approximately $28,000. IMG Wealth Management Inc. bought a new position in shares of Synopsys during the 1st quarter valued at approximately $30,000. Finally, Atlas Capital Advisors Inc. bought a new position in shares of Synopsys during the 4th quarter valued at approximately $32,000. 85.47% of the stock is currently owned by institutional investors.
Synopsys Company Profile
(
Get Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.